![](https://www.innovations-report.com/wp-content/uploads/2013/06/crop-in-fields-300x200.jpg)
Lalistat: A Promising Antiviral Agent Against Common Viruses
![](https://www.innovations-report.com/wp-content/themes/innovation-report-2/assets/dist/img/placeholder-single-thumbnail.png)
The present new therapeutic lysosomal lipase A antagonist Lalistat is a convenient and reliable pharmaceutical agent to prevent virus infections such as HCV, Influenza Typ A (H5N1) and other virus infections without any risks of reinfections and development of resistance mutations.
Further information: PDF
Bayerische Patentallianz GmbH
Phone: +49 89 5480177-0
Contact
Peer Biskup
As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.